RNA binding protein QKI inhibits the ischemia/reperfusion-induced apoptosis in neonatal cardiomyocytes

Cellular Physiology and Biochemistry

Volumn 28, Issue 4, 2011, Pages 593-602

  Guo, Wangang ^a,b   Shi, Xiaoqin ^c   Liu, Anheng ^d   Yang, Guodong ^a   Yu, Fang ^a   Zheng, Qiangsun ^b   Wang, Zikuan ^b   Allen, David G ^e   Lu, Zifan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c XI AN NO 4 HOSPITAL   (China)

^d Beijing 307 Hospital   (China)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Apoptosis; Cardiomyocytes; FoxO1; Ischemia reperfusion; QKI

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; RNA BINDING PROTEIN; RNA BINDING PROTEIN QKI5; RNA BINDING PROTEIN QKI6; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE SIMULATION; DNA FRAGMENTATION; DNA LADDERING; FLOW CYTOMETRY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC SUSCEPTIBILITY; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; IMMUNOFLUORESCENCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

EID: 83755195406     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335755     Document Type: Article

References (32)

1. Sidman RL, Dickie MM, Appel SH: Mutant mice (quaking and jimpy) with deficient myelination in the central nervous system. Science 1964;144:309-311.
2. Ebersole TA, Chen Q, Justice MJ, Artzt K: The quaking gene product necessary in embryogenesis and myelination combines features of RNA binding and signal transduction proteins. Nat Genet 1996;12:260-265. (Pubitemid 26080084)
3. Hardy RJ, Loushin CL, Friedrich VL, Chen Q, Ebersole TA, Lazzarini RA, Artzt K: Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice. J Neurosci 1996;16:7941-7949. (Pubitemid 26405057)
4. Kondo T, Furuta T, Mitsunaga K, Ebersole TA, Shichiri M, Wu J, Artzt K, Yamamura K, Abe K: Genomic organization and expression analysis of the mouse qkI locus. Mamm Genome 1999;10:662-669. (Pubitemid 29393670)
5. Li Z, Zhang Y, Li D, Feng Y: Destabilization and mislocalization of myelin basic protein mRNAs in quaking dysmyelination lacking the QKI RNAbinding proteins. J Neurosci 2000;20:4944-4953. (Pubitemid 30421698)
6. Zhang Y, Feng Y: Distinct molecular mechanisms lead to diminished myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase in qk(v) dysmyelination. J Neurochem 2001;77:165-172. (Pubitemid 32245090)
7. Larocque D, Pilotte J, Chen T, Cloutier F, Massie B, Pedraza L, Couture R, Lasko P, Almazan G, Richard S: Nuclear retention of MBP mRNAs in the quaking viable mice. Neuron 2002;36:815-829. (Pubitemid 35447854)
8. Zhang Y, Lu Z, Ku L, Chen Y, Wang H, Feng Y: Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J 2003;22:1801-1810. (Pubitemid 36460137)
9. Vernet C, Artzt K: STAR, a gene family involved in signal transduction and activation of RNA. Trends Genet 1997;13:479-84. (Pubitemid 28004921)
10. Galarneau A, Richard S: The STAR RNA binding proteins GLD-1, QKI, SAM68 and SLM-2 bind bipartite RNA motifs. BMC Mol Biol 2009;10:47.
11. Galarneau A, Richard S: Target RNA motif and target mRNAs of the Quaking STAR protein. Nat Struct Mol Biol 2005;12:691-698. (Pubitemid 43086275)
12. Wong A, Woodcock EA: FoxO proteins and cardiac pathology. Adv Exp Med Biol 2009;665:78-89.
13. Evans-Anderson HJ, Alfieri CM, Yutzey KE: Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res 2008;102:686-694. (Pubitemid 351457856)
14. Ni YG, Berenji K, Wang N, Oh M, Sachan N, Dey A, Cheng J, Lu G, Morris DJ, Castrillon DH, Gerard RD, Rothermel BA, Hill JA: Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling. Circulation 2006;114:1159-1168. (Pubitemid 44386480)
15. Li J, Zhang H, Wu F, Nan Y, Ma H, Guo W, Wang H, Ren J, Das UN, Gao F: Insulin inhibits tumor necrosis factor-alpha induction in myocardial ischemia/ reperfusion: role of Akt and endothelial nitric oxide synthase phosphorylation. Crit Care Med 2008;36:1551-1558. (Pubitemid 351620675)
16. Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, Murcia JM: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 1998.273:33533-33539. (Pubitemid 29005737)
17. Stephanou A, Scarabelli TM, Brar BK, Nakanishi Y, Matsumura M, Knight RA, Latchman DS: Induction of apoptosis and Fas receptor/Fas ligand expression by ischemia/reperfusion in cardiac myocytes requires serine 727 of the STAT-1 transcription factor but not tyrosine 701. J Biol Chem 2001;276:28340-28347.
18. Yellon DM, Hausenloy DJ: Myocardial reperfusion injury. N Engl J Med 2007;357:1121-1135.
19. Zhao ZQ, Velez DA, Wang NP, Hewan-Lowe KO, Nakamura M, Guyton RA, Vinten-Johansen J: Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001;6:279-290. (Pubitemid 32708522)
20. Logue SE, Gustafsson AB, Samali A, Gottlieb RA: Ischemia/reperfusion injury at the intersection with cell death. J Mol Cell Cardiol 2005;38:21-33. (Pubitemid 40044759)
21. Li Z, Takakura N, Oike Y, Imanaka T, Araki K, Suda T, Kaname T, Kondo T, Abe K, Yamamura K: Defective smooth muscle development in qkI-deficient mice. Dev Growth Differ 2003;45:449-462. (Pubitemid 38067911)
22. Bohnsack BL, Lai L, Northrop JL, Justice MJ, Hirschi KK: Visceral endoderm function is regulated by quaking and required for vascular development. Genesis 2006;44:93-104.
23. Noveroske JK, Lai L, Gaussin V, Northrop JL, Nakamura H, Hirschi KK, Justice MJ: Quaking is essential for blood vessel development. Genesis 2002;32:218-230. (Pubitemid 34260453)
24. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868. (Pubitemid 29165088)
25. Morris JB, Kenney B, Huynh H, Woodcock EA: Regulation of the proapoptotic factor FOXO1 (FKHR) in cardiomyocytes by growth factors and alpha1-adrenergic agonists. Endocrinology 2005;146:4370-4376. (Pubitemid 41324033)
26. Lopez-Neblina F, Toledo-Pereyra LH: Phosphoregulation of signal transduction pathways in ischemia and reperfusion. J Surg Res 2006;134:292-299. (Pubitemid 44092807)
27. Suhara T, Kim HS, Kirshenbaum LA, Walsh K: Suppression of Akt signaling induces Fas ligand expression: involvement of caspase and Jun kinase activation in Akt-mediated Fas ligand regulation. Mol Cell Biol 2002;22:680-691. (Pubitemid 34027511)
28. Sussman MA: Cause of death: A "broken" MEKK. J Mol Cell Cardiol 2006;40:593-596.
29. Asada S, Daitoku H, Matsuzaki H, Saito T, Sudo T, Mukai H, Iwashita S, Kako K, Kishi T, Kasuya Y, Fukamizu A: Mitogenactivated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell Signal 2007;19:519-527. (Pubitemid 46107803)
30. Sengupta A, Molkentin JD, Yutzey KE: FoxO transcription factors promote autophagy in cardiomyocytes. J Biol Chem 2009;284:28319-28331.
31. Schumacher B, Hanazawa M, Lee MH, Nayak S, Volkmann K, Hofmann ER, Hengartner M, Schedl T, Gartner A: Translational repression of C. elegans p53 by GLD-1 regulates DNA damage-induced apoptosis. Cell 2005;120:357-368. (Pubitemid 40222430)
32. Pilotte J, Larocque D, Richard S Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer. Genes Dev 2001 15 845-858. (Pubitemid 32295066)